ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 55 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $635,898 | +236.5% | 107,688 | +177.6% | 0.00% | – |
| Q2 2022 | $189,000 | +1081.2% | 38,788 | +5513.3% | 0.00% | – |
| Q1 2021 | $16,000 | -85.5% | 691 | -80.0% | 0.00% | – |
| Q4 2020 | $110,000 | +1000.0% | 3,455 | +757.3% | 0.00% | – |
| Q3 2020 | $10,000 | -41.2% | 403 | -42.0% | 0.00% | – |
| Q2 2020 | $17,000 | – | 695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 4,768,181 | $116,820,000 | 11.19% |
| Memorial Sloan Kettering Cancer Center | 602,272 | $14,756,000 | 9.10% |
| Euclidean Capital LLC | 996,734 | $24,420,000 | 8.17% |
| Invus Financial Advisors, LLC | 1,007,575 | $24,686,000 | 5.66% |
| EcoR1 Capital, LLC | 3,092,218 | $75,759,000 | 3.36% |
| Ally Bridge Group (NY) LLC | 413,061 | $10,120,000 | 1.94% |
| EMERALD ADVISERS, LLC | 615,511 | $15,080,000 | 0.54% |
| Orbimed Advisors | 2,337,574 | $57,271,000 | 0.54% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 624,210 | $15,293,000 | 0.51% |
| Casdin Capital, LLC | 601,515 | $14,737,000 | 0.44% |